Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: KanadaFázis nélkül

Transition and Transfer of Congenital Heart Disease Care From Pediatrics to Adulthood

A legfontosabb adatok

Ki végzi
Ottawa Heart Institute Research Corporation
Hol
Ottawa (Kanada)A helyszín megnézése
Azonosító
Állapot
Toboroz
Résztvevők
200 fő, tervezett
Kezdés
2024. jún. 1.
Várható befejezés
2026. dec. 31.
A vizsgálat típusa
Megfigyeléses
A vizsgált kezelések
  • Multi-pronged transfer program
A regiszteradat frissítve
2026. július 2.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults with congenital heart disease (a heart problem present from birth) who are newly referred to the adult heart clinic at the University of Ottawa Heart Institute. They can be referred from the children's hospital or from community doctors.

Életkor
18 Years and older
Nem
All sexes
A betegség stádiuma
Congenital heart disease, new patients waiting for a first visit with the adult congenital heart team

A regiszter feltételei, szó szerint

Mind a 2 feltétel megnézéseKevesebb

Ki vehet részt

  • All new patients with congenital heart disease referred from the pediatric hospital and the community

Ki nem vehet részt

  • None

Helyszínek itt: Kanada

  • University of Ottawa Heart InstituteOttawa, KanadaContact: Markus Schwerzmann, MDRésztvevőt keres

A vizsgálatról

Mit akar kideríteni a vizsgálat

Adults with congenital heart disease (CHD) are a growing patient population in need of ongoing specialized care. Lapses in appropriate transition and transfer processes from childhood to adulthood in CHD care can lead to loss in follow up, late detection of new or evolving cardiac complications and negative patient outcomes. Therefore, it is vital that a robust transition and transfer process is established. Through a retrospective study completed recently at the University of Ottawa Heart Institute (UOHI) we have shown that the average wait time to be assessed by an adult congenital heart disease (ACHD) specialist is about 10 months and within this wait period 1 in 8 ACHD patients have a decline in their health.

A teljes eredeti leírásKevesebb

The goal of this study is to specifically reduce negative patient outcomes during this wait period. We aim to achieve this by (i) establishing a program to ensure early detection of patients at risk of deterioration and (ii) providing additional support to these patients. The program is designed to have a multipronged approach including tools to disseminate concise patient specific information among care providers, maintain open line of communication with patients on the waitlist and promote patient education.

We plan to improve our transition care by creating a multi-pronged transfer program specifically for patients on the wait list composed of a nurse check in, creation of a diagnosis summary, education day and combined pediatric cardiology/ACHD handover videocall (described below). This program is planned as part of our care pathway and will be offered to all patients on the wait list. We intend to document the efficacy of this transition program to improve transition care by assessing patient reported outcomes and clinical outcomes of the patients who consent to complete additional questionnaires.

The multi-pronged program will include the following:

1. ACHD nurse check-in (patient check-in via phone call or zoom from the ACHD nurse within 1 month of receiving referral) - allows early establishment of clinical relationship with the patient, screen for risk factors for deterioration and provision of ACHD clinic contact information to enable open line of communication. Patients considered at risk for deterioration on the wait-list based on this check-in conversation will be triaged for a more urgent first consult at the ACHD clinic. 2. Quick glance diagnosis summary (Electronic on Epic MyChart) - will be created during nurse check in and will be used to disseminate concise patient specific information among health care workers and acts as a reference for the patients. 3. Organization of an ACHD patient education day (half day hybrid event every 6 months) - allows formal introduction to the ACHD team, provides information session on ACHD care and lowers patients' threshold to inform the ACHD team in case of clinical deterioration. 4. Combined pediatric cardiology and ACHD handover video call at time of transfer - allows effective and efficient handover of patient care from pediatric to adult care and facilitates the coordination of care during the transfer period.

These four components of the program work together to provide tools to disseminate concise patient specific information among care providers, maintain open line of communication with patients on the waitlist and promote patient education.

A vizsgálat csoportja

  • Patients with congenital heart disease referred to the University of Ottawa Heart Institute

    We aim to include all the patients referred to the UOHI ACHD program in our multipronged transfer program. This will include patients from the pediatric hospital (CHEO) and community referrals.

    Kezelés: Multi-pronged transfer program

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Transition and Transfer of Congenital Heart Disease Care From Pediatrics to Adulthood.
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2026. július 2.